MedTrace Logo

Transdiagnostic Treatment for Anxiety Disorders in Two Cities of México

NCT03916315 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2020-07-07

No results posted yet for this study

Summary

This study evaluates the effectiveness of The Unified Transdiagnostic Protocol, a psychological treatment for the intervention of a broad range of anxiety disorders. It is compared the effectiveness of the treatment with the changes of the same participants before and after the treatment and a control group. The changes are being assessed through subjective measures such as psychometrics and objective measures such as Electroencelophalography.

Conditions

  • Anxiety Disorders

Interventions

BEHAVIORAL

Transdiagnostic Treatment

The Unified Transdiagnostic Protocol (PUT) is a cognitive-behavioral treatment focused on emotions. "The PUT was developed to be applicable to anxiety disorders, mood disorders, as well as other disorders in which anxiety and emotional dysregulation play an important role, such as many somatoform and dissociative disorders". The PUT proposal includes 8 modules, of which 5 are nuclear, it is recommended to give these modules between 11 to 17 sessions with a duration of one hour each.

Sponsors & Collaborators

  • Universidad Autonoma de Ciudad Juarez

    collaborator OTHER

  • Universidad Autonoma de Baja California

    lead OTHER

Principal Investigators

  • Alejandro Dominguez-Rodriguez, PhD · Autonomous University of Baja California

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-04
Primary Completion
2020-01-06
Completion
2020-01-06

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03916315 on ClinicalTrials.gov